Integrative Research Laboratories Sweden AB
556922-0444ActiveDeveloping novel CNS drugs for Parkinson's disease using proprietary technology.
Yleiskatsaus
- 20–49
- Työntekijät
- 100–500milj SEK
- Liikevaihto
- 2013
- Perustettu
Avainpäättäjät
Kristina Torfgård
CEO
Anders Vedin
Chairman of the Board
Clas Sonesson
Chief Scientific Officer (CSO)
Hans-Peter Ostler
Board Member
+14 lisää yhteystietoja Funnelfeedrissä
Kuvaus
IRLAB Therapeutics AB is a rapidly growing, publicly traded biotechnology company headquartered in Gothenburg, Sweden. The organization is dedicated to transforming life for people suffering from Parkinson’s disease and other Central Nervous System (CNS) disorders. IRLAB utilizes its unique, proprie...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556922044401
Päättäjät
18 yhteystietoa FunnelfeedrissäKristina Torfgård
CEO
Anders Vedin
Chairman of the Board
Clas Sonesson
Chief Scientific Officer (CSO)
Hans-Peter Ostler
Board Member
Carola Lemne
Chair of the Board
Viktor Siewertz
CFO
Richard Godfrey
CEO
Rein Piir
Board Member
Christer Nordstedt
Board Member
Gunnar Olsson
Board Member
Veronica Wallin
Board Member
Nicholas Waters
Executive Vice President and Head of R&D
Daniel Johnsson
Board Member
Hans-Olov Olsson
Board Member
Joakim Tedroff
Chief Medical Officer (CMO)
Gustaf Albèrt
Chief Financial Officer (CFO)
Peder Svensson
Director of Computational Chemistry & Biology and Chief Information Officer (CIO)
Susanna Holm Waters
Director of Systems Pharmacology
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäLobSor Pharmaceuticals Aktiebolag
3 työntekijätDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
TIKOMED AB
1–4 työntekijätDeveloping novel drug candidates for neurodegenerative diseases via partnerships.
ScandiBio Therapeutics AB
0 työntekijätAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
Key2Brain AB
10–19 työntekijätDeveloping proprietary technology for next-generation brain targeting therapeutics.
AlzeCure Pharma AB
10–19 työntekijätSwedish pharma developing CNS drugs for Alzheimer's and pain.
Selaa lisää
Kysymyksiä yrityksestä Integrative Research Laboratories Sweden AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo